Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by bthoughtson Dec 22, 2014 12:32pm

281 Views

Post# 23256278

RE:under 7 bucks a share. "unobstructed path"

Hey guys thanks for sharing the news update and opinon on GUD.

A few quick questions that I'm still trying to wrap my head around

1) Why is the price controlled to stay at or around the $6.75 range? Who is doing this and what is the reason?

2) The Long Zone Holdings Inc, does this mean Goodman and Jeffrey also purchased additional shares for $6.75 but under the company name Long Zone Holdings? What would be the reason for this, why not just purchase on the market since it's been averaging $6.75 a share anyhow?

Any feedback or reponses would be greatly appreciated, thanks head of time!

Bullboard Posts

5 steps to mastering risk management in the stock market